Christopher R. McEvoy

2.5k total citations
33 papers, 1.8k citations indexed

About

Christopher R. McEvoy is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Christopher R. McEvoy has authored 33 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Christopher R. McEvoy's work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (11 papers) and Infectious Diseases and Tuberculosis (5 papers). Christopher R. McEvoy is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (11 papers) and Infectious Diseases and Tuberculosis (5 papers). Christopher R. McEvoy collaborates with scholars based in Australia, South Africa and United States. Christopher R. McEvoy's co-authors include Robin M. Warren, Paul D. van Helden, Nicolaas C. Gey van Pittius, T. C. Victor, M. Hanekom, S. L. Ndabambi, Thomas C. Victor, Gian van der Spuy, Benjamin P. Howden and Timothy P. Stinear and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Christopher R. McEvoy

31 papers receiving 1.7k citations

Peers

Countries citing papers authored by Christopher R. McEvoy

Since Specialization

Citations

This map shows the geographic impact of Christopher R. McEvoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. McEvoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. McEvoy more than expected).

Fields of papers citing papers by Christopher R. McEvoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. McEvoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. McEvoy. The network helps show where Christopher R. McEvoy may publish in the future.

Co-authorship network of co-authors of Christopher R. McEvoy

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. McEvoy. A scholar is included among the top collaborators of Christopher R. McEvoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. McEvoy. Christopher R. McEvoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspective 2025 ·Pathology ·Christopher R. McEvoy, Catherine Mitchell, Owen W.J. Prall, (unknown), Andrew Fellowes, (unknown), (unknown), Roxane Legaie, (unknown), Richard Lupat, Christopher Angel, Christine Khoo, Jia‐Min Pang, Cameron Snell, Stephen B. Fox, Jeremy Lewin	0
2	Development of Novel Anticancer Pyrazolopyrimidinones Targeting Glioblastoma 2025 ·ChemMedChem ·(unknown), Natalia Bednarz‐Knoll, Christopher R. McEvoy, John C. Stephens, James F. Curtin, Gemma K. Kinsella	0
3	ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literature 2022 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Michael S. Hildebrand, (unknown), (unknown), Christopher R. McEvoy, (unknown), (unknown)	9
4	A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors 2020 ·Laboratory Investigation ·Christopher R. McEvoy, Holly Holliday, Niko Thio, Catherine Mitchell, (unknown), (unknown), (unknown), Huiling Xu, Stephen Lade, Judy Browning, Elena A. Takano, David J. Byrne, Anthony J. Gill, Cuong Duong, Jason Li, Andrew Fellowes, Stephen B. Fox, Alexander Swarbrick, Owen W.J. Prall	16
5	Emerging entities in NUTM1‐rearranged neoplasms 2020 ·Genes Chromosomes and Cancer ·Christopher R. McEvoy, Stephen B. Fox, Owen W.J. Prall	53
6	SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response 2018 ·npj Precision Oncology ·Christopher R. McEvoy, (unknown), (unknown), Huei San Leong, Huiling Xu, Deme Karikios, (unknown), Owen W.J. Prall, Andrew Fellowes, Stephen B. Fox	28
7	Comparative Analysis of Mycobacterium tuberculosis pe and ppe Genes Reveals High Sequence Variation and an Apparent Absence of Selective Constraints 2012 ·PLoS ONE ·Christopher R. McEvoy, Ruben Cloete, Borna Müller, Anita C. Schürch, Paul D. van Helden, Sébastien Gagneux, Robin M. Warren, Nicolaas C. Gey van Pittius	77
8	Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux 2011 ·American Journal of Respiratory and Critical Care Medicine ·Gail Louw, Robin M. Warren, Nicolaas C. Gey van Pittius, (unknown), (unknown), Rogélio Hernández‐Pando, Christopher R. McEvoy, Melanie Grobbelaar, Megan Murray, Paul D. van Helden, Thomas C. Victor	129
9	Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR 2011 ·PLoS Pathogens ·Benjamin P. Howden, Christopher R. McEvoy, (unknown), Kyra Chua, Wei Gao, Paul F. Harrison, Jan Bell, Geoffrey W. Coombs, Vicki Bennett‐Wood, Jessica L. Porter, Roy M. Robins‐Browne, John K. Davies, Torsten Seemann, Timothy P. Stinear	297
10	Mycobacterium tuberculosis Beijing genotype: A template for success 2011 ·Tuberculosis ·M. Hanekom, Nicolaas C. Gey van Pittius, Christopher R. McEvoy, T. C. Victor, Paul D. van Helden, Robin M. Warren	123
11	Proteogenomic Analysis of Polymorphisms and Gene Annotation Divergences in Prokaryotes using a Clustered Mass Spectrometry-Friendly Database 2010 ·Molecular & Cellular Proteomics ·Gustavo A. de Souza, Magnus Ø. Arntzen, Suereta Fortuin, Anita C. Schürch, Hiwa Målen, Christopher R. McEvoy, Dick van Soolingen, Bernd Thiede, Robin M. Warren, Harald G. Wiker	52
12	Using a Label-free Proteomics Method to Identify Differentially Abundant Proteins in Closely Related Hypo- and Hypervirulent Clinical Mycobacterium tuberculosis Beijing Isolates 2010 ·Molecular & Cellular Proteomics ·Gustavo A. de Souza, Suereta Fortuin, Diana Aguilar, Rogélio Hernández‐Pando, Christopher R. McEvoy, Paul D. van Helden, Christian Koehler, Bernd Thiede, Robin M. Warren, Harald G. Wiker	54
13	Multiple, independent, identical IS6110 insertions in Mycobacterium tuberculosis PPE genes 2009 ·Tuberculosis ·Christopher R. McEvoy, Robin M. Warren, Paul D. van Helden, Nicolaas C. Gey van Pittius	8
14	Maternal separation alters nerve growth factor and corticosterone levels but not the DNA methylation status of the exon 17 glucocorticoid receptor promoter region 2009 ·Metabolic Brain Disease ·Willie M. U. Daniels, (unknown), (unknown), Christopher R. McEvoy, Michael J. Zigmond, Vivienne A. Russell, Dan J. Stein	84
15	A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance 2009 ·Antimicrobial Agents and Chemotherapy ·(unknown), Robin M. Warren, Nicolaas C. Gey van Pittius, Christopher R. McEvoy, Paul D. van Helden, T. C. Victor	195
16	Discordance between Mycobacterial Interspersed Repetitive-Unit-Variable-Number Tandem-Repeat Typing and IS6110Restriction Fragment Length Polymorphism Genotyping for Analysis ofMycobacterium tuberculosisBeijing Strains in a Setting of High Incidence of Tuberculosis 2008 ·Journal of Clinical Microbiology ·M. Hanekom, Gian van der Spuy, Nicolaas C. Gey van Pittius, Christopher R. McEvoy, Kim G.P. Hoek, S. L. Ndabambi, A. Jordaan, T. C. Victor, Paul D. van Helden, Robin M. Warren	53
17	The role of IS6110 in the evolution of Mycobacterium tuberculosis 2007 ·Tuberculosis ·Christopher R. McEvoy, (unknown), Nicolaas C. Gey van Pittius, Thomas C. Victor, Paul D. van Helden, Robin M. Warren	105
18	Evidence for whole chromosome 6 loss and duplication of the remaining chromosome in acute lymphoblastic leukemia 2003 ·Genes Chromosomes and Cancer ·Christopher R. McEvoy, Alexander A. Morley, F A Firgaira	23
19	Frequency and genetic basis of MHC, beta‐2‐microglobulin and MEMO‐1 loss of heterozygosity in sporadic breast cancer 2002 ·Tissue Antigens ·Christopher R. McEvoy, R. Seshadri, Alexander A. Morley, F A Firgaira	7
20	HRAS1 Rare Minisatellite Alleles and Breast Cancer in Australian Women Under Age Forty Years 1999 ·JNCI Journal of the National Cancer Institute ·F A Firgaira, R. Seshadri, Christopher R. McEvoy, Gillian S. Dite, Graham G. Giles, (unknown), Melissa C. Southey, Deon J. Venter, JL Hopper	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact